Spetzler David Baxley: insider trades.
Spetzler David Baxley reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($14.8M), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Spetzler David Baxley
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Caris Life Sciences, Inc. (CAI) | Officer · President | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-04 | Caris Life Sciences, Inc. | S | 119,212 | $24.76 | 1,182,871 | Form 4 |
| 2026-09-04 | Caris Life Sciences, Inc. | M | 250,000 | $2.44 | 1,302,083 | Form 4 |
| 2026-09-03 | Caris Life Sciences, Inc. | M | 1,000,000 | $2.44 | 1,530,083 | Form 4 |
| 2026-09-03 | Caris Life Sciences, Inc. | S | 393,100 | $24.76 | 1,136,983 | Form 4 |
| 2026-09-03 | Caris Life Sciences, Inc. | S | 84,900 | $25.32 | 1,052,083 | Form 4 |
Questions
What stock did Spetzler David Baxley buy or sell?
Spetzler David Baxley reported 5 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($14.8M), across 1 company.
Is Spetzler David Baxley the same person as other filers with this name?
This page covers SEC CIK 2071953 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/spetzler-david-baxley-2071953.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.